d-alpha tocopherol has been researched along with cupric chloride in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 7 (70.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gotoh, N; Komuro, E; Niki, E; Noguchi, N; Shimizu, K; Tsuchiya, J | 1 |
Esterbauer, H; Jürgens, G; Quehenberger, O; Zadravec, S | 1 |
Bräutigam, C; Engelmann, B; Thiery, J | 1 |
Boulet, L; Davignon, J; de Langavant, GC; Dubreuil-Quidoz, S; Leboeuf, N; Lussier-Cacan, S; Naruszewicz, M; Roederer, G | 1 |
Barbas, C; Bonet, B; Bonet, MV; Castro, M; Fraile, MV; Herrera, E; Viana, M | 1 |
Nyyssönen, K; Porkkala-Sarataho, E; Salonen, JT | 1 |
Lippert, TH; Mueck, AO; Seegar, H | 1 |
Burkitt, MJ; Inoue, S; Kawanishi, S; Milne, L; Murata, M; Yamashita, N | 1 |
Fainaru, M; Lichtenberg, D; Pinchuk, I; Raveh, O; Schaffer, Z; Schnitzer, E | 1 |
Bonet, B; Herrera, E; Otero, P | 1 |
1 trial(s) available for d-alpha tocopherol and cupric chloride
Article | Year |
---|---|
Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men.
Topics: Adult; Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Ascorbic Acid; beta Carotene; Cholesterol, LDL; Copper; Dietary Fats; Double-Blind Method; Humans; Hypercholesterolemia; Linoleic Acid; Linoleic Acids; Lipids; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Oxidation-Reduction; Pravastatin; Risk Factors; Smoking; Vitamin E | 1996 |
9 other study(ies) available for d-alpha tocopherol and cupric chloride
Article | Year |
---|---|
Antioxidant activities of probucol against lipid peroxidations.
Topics: Antioxidants; Benzhydryl Compounds; Copper; Electron Spin Resonance Spectroscopy; Free Radicals; Hexanes; Humans; Linoleic Acids; Lipid Peroxidation; Lipoproteins, LDL; Liposomes; Oxidation-Reduction; Phosphatidylcholines; Probucol; Vitamin E | 1992 |
Oxidation of human low density lipoprotein initiated by copper (II) chloride.
Topics: Aldehydes; beta Carotene; Carotenoids; Copper; Free Radicals; Humans; Kinetics; Lipoproteins, LDL; Oxidation-Reduction; Vitamin E | 1988 |
Plasmalogen phospholipids as potential protectors against lipid peroxidation of low density lipoproteins.
Topics: Adult; Amidines; Copper; Female; Humans; Kinetics; Lipid Peroxidation; Lipoproteins, LDL; Male; Oxidative Stress; Phosphatidylcholines; Phosphatidylethanolamines; Plasmalogens; Vitamin E | 1994 |
Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients.
Topics: Adult; Antioxidants; Cholesterol, HDL; Cholesterol, VLDL; Copper; Fish Oils; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Lipid Peroxidation; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Probucol; Thiobarbituric Acid Reactive Substances; Triglycerides; Vitamin E | 1993 |
In vitro effects of a flavonoid-rich extract on LDL oxidation.
Topics: Antioxidants; Butylated Hydroxytoluene; Cardiovascular Diseases; Copper; Edetic Acid; Flavonoids; Humans; Lipid Peroxidation; Lipoproteins, LDL; Oxidation-Reduction; Plant Extracts; Plants, Medicinal; Thiobarbituric Acid Reactive Substances; Vitamin E | 1996 |
Effect of melatonin and metabolites on copper-mediated oxidation of flow density lipoprotein.
Topics: Adult; Copper; Female; Humans; Lipoproteins, LDL; Melatonin; Oxidation-Reduction; Vitamin E | 1997 |
Alpha-tocopherol induces oxidative damage to DNA in the presence of copper(II) ions.
Topics: Antioxidants; Copper; DNA; DNA Damage; Drug Interactions; Genes, p53; Humans; Liposomes; Oxygen; Superoxides; Vitamin E | 1998 |
Kinetic analysis of copper-induced peroxidation of HDL, autoaccelerated and tocopherol-mediated peroxidation.
Topics: Copper; Humans; Kinetics; Lipid Peroxidation; Lipoproteins, HDL; Models, Chemical; Oxidation-Reduction; Vitamin E | 2000 |
Dual effect of glucose on LDL oxidation: dependence on vitamin E.
Topics: Antioxidants; Arteriosclerosis; Copper; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Glucose; Humans; Lipoproteins, LDL; Oxidation-Reduction; Thiobarbituric Acid Reactive Substances; Vitamin E | 2002 |